Karmanos Cancer Institute Enhances Clinical Trials App with Advanced Search and Accessibility Features
Event summary
- Karmanos Cancer Institute launched an updated version of its KCI Clinical Trials App on June 12, 2026, with enhanced usability and accessibility features.
- The app now includes over 160 clinical trial protocols across 35 cancer types, led by 33 principal investigators at 13 locations.
- New features include faster search capabilities, direct contact options with Karmanos experts, and offline functionality for low-connectivity environments.
The big picture
Karmanos Cancer Institute's app update aligns with the broader trend of digital health tools empowering patients and streamlining clinical trial access. As healthcare systems increasingly integrate technology into patient care, Karmanos positions itself as a leader in oncology by offering a specialized platform that consolidates its unique trial offerings. The app's enhancements could also strengthen referrals from physicians, reinforcing Karmanos' role as a regional hub for advanced cancer treatment.
What we're watching
- Patient Adoption
- How the enhanced app features will impact patient engagement and participation in clinical trials at Karmanos.
- Physician Utilization
- Whether referring physicians will increasingly rely on the app to guide treatment decisions for cancer patients.
- Competitive Differentiation
- The pace at which Karmanos can leverage this tool to attract more patients seeking cutting-edge cancer treatments.
Related topics